IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae (NYSE: NVTA), a leading genetics and synthetic biology company, and ArcherDX, a leading genomics analysis company innovating in precision oncology, today announced the companies have entered into an agreement to combine. The combined company aims to advance care for cancer patients by accelerating adoption of genetics . Integrating germline testing, tumor profiling and liquid biopsy … Read more

Why Biomolecules Are A Key Area Of Synthetic Biology Startup Activity

Why Biomolecules Are A Key Area Of Synthetic Biology Startup Activity

According to McKinsey Global Institute (MGI), several trends in science and technology are powering human understanding of biological processes and enabling us to engineer them for myriad uses. MGI says that innovations cover a wide range of interdisciplinary fields in four key arenas: biomolecules, biosystems, biomachine interfaces, and biocomputing. Major breakthroughs in each are reinforcing … Read more

Sana Biotech Completes Massive Initial Financing Round

Sana Biotech Completes Massive Initial Financing Round

Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches of its initial financing, raising over $700 million.  Sana’s shareholders include ARCH Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board, Baillie Gifford, F-Prime Capital, Alaska Permanent Fund, the Public Sector Pension Investment Board, Bezos Expeditions, GV, … Read more

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

ArcherDX, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a companion diagnostic (CDx) to detect neurotrophic receptor tyrosine kinase (NTRK) gene fusions that lead to the formation and growth of cancer. ArcherDX’s NGS technology utilizes proprietary Anchored Multiplex PCR … Read more

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

Advances in biological sciences, accelerated by computing, automation, and artificial intelligence (AI), is fueling a new wave of innovation that will impact economies and societies that will surpass the industrial revolution. In fact, these new capabilities and applications are already improving our response to global challenges from climate change to pandemics. But these innovations come … Read more